BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 37673459)

  • 21. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
    Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
    J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations.
    Hoshino A; Okada S; Yoshida K; Nishida N; Okuno Y; Ueno H; Yamashita M; Okano T; Tsumura M; Nishimura S; Sakata S; Kobayashi M; Nakamura H; Kamizono J; Mitsui-Sekinaka K; Ichimura T; Ohga S; Nakazawa Y; Takagi M; Imai K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Kojima S; Nonoyama S; Morio T; Kanegane H
    J Allergy Clin Immunol; 2017 Jul; 140(1):223-231. PubMed ID: 27939403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.
    Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B
    Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pax5: the guardian of B cell identity and function.
    Cobaleda C; Schebesta A; Delogu A; Busslinger M
    Nat Immunol; 2007 May; 8(5):463-70. PubMed ID: 17440452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-cell identity as a metabolic barrier against malignant transformation.
    Chan LN; Müschen M
    Exp Hematol; 2017 Sep; 53():1-6. PubMed ID: 28655536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal conversion of B lymphoid leukemia reveals cross-lineage transfer of malignant states.
    Somasundaram R; Åhsberg J; Okuyama K; Ungerbäck J; Lilljebjörn H; Fioretos T; Strid T; Sigvardsson M
    Genes Dev; 2016 Nov; 30(22):2486-2499. PubMed ID: 27913602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
    Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
    J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genes and childhood leukemia.
    Kęsy J; Januszkiewicz-Lewandowska D
    Postepy Hig Med Dosw (Online); 2015 Mar; 69():302-8. PubMed ID: 25748621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of transcription factor deregulation in lymphoid cell transformation.
    O'Neil J; Look AT
    Oncogene; 2007 Oct; 26(47):6838-49. PubMed ID: 17934490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAX5 fusion genes in acute lymphoblastic leukemia: A literature review.
    Fouad FM; Eid JI
    Medicine (Baltimore); 2023 May; 102(20):e33836. PubMed ID: 37335685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).
    Burlet B; Ramla S; Fournier C; Abrey-Recalde MJ; Sauter C; Chrétien ML; Rossi C; Duffourd Y; Ragot S; Buriller C; Tournier B; Chapusot C; Nadal N; Racine J; Guy J; Bailly F; Martin L; Casasnovas O; Bastie JN; Caillot D; Albuisson J; Broccardo C; Thieblemont C; Delva L; Maynadié M; Aucagne R; Callanan MB
    Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional control of pre-B cell development and leukemia prevention.
    Pang SH; Carotta S; Nutt SL
    Curr Top Microbiol Immunol; 2014; 381():189-213. PubMed ID: 24831348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
    Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare
    Miyamoto S; Urayama KY; Arakawa Y; Koh K; Yuza Y; Hasegawa D; Taneyama Y; Noguchi Y; Yanagimachi M; Inukai T; Ota S; Takahashi H; Keino D; Toyama D; Takita J; Tomizawa D; Morio T; Koike K; Moriwaki K; Sato Y; Fujimura J; Morita D; Sekinaka Y; Nakamura K; Sakashita K; Goto H; Manabe A; Takagi M
    Pediatr Hematol Oncol; 2024; 41(1):81-87. PubMed ID: 37129918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
    Mullighan CG; Su X; Zhang J; Radtke I; Phillips LA; Miller CB; Ma J; Liu W; Cheng C; Schulman BA; Harvey RC; Chen IM; Clifford RJ; Carroll WL; Reaman G; Bowman WP; Devidas M; Gerhard DS; Yang W; Relling MV; Shurtleff SA; Campana D; Borowitz MJ; Pui CH; Smith M; Hunger SP; Willman CL; Downing JR;
    N Engl J Med; 2009 Jan; 360(5):470-80. PubMed ID: 19129520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular mechanisms in leukemogenesis].
    Mitani K
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1107-12. PubMed ID: 12145988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Ou Z; Sherer M; Casey J; Bakos HA; Vitullo K; Hu J; Friehling E; Gollin SM; Surti U; Yatsenko SA
    Cytogenet Genome Res; 2016; 150(3-4):242-252. PubMed ID: 28214896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tungsten Blocks Murine B Lymphocyte Differentiation and Proliferation Through Downregulation of IL-7 Receptor/Pax5 Signaling.
    Wu TH; Bolt AM; Chou H; Plourde D; De Jay N; Guilbert C; Young YK; Kleinman CL; Mann KK
    Toxicol Sci; 2019 Jul; 170(1):45-56. PubMed ID: 30912803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.